Cloned animal products in the human food chain: FDA should protect American consumers.

Publisher: Food and Drug Law Institute Country of Publication: United States NLM ID: 9215384 Publication Model: Print Cited Medium: Print ISSN: 1064-590X (Print) Linking ISSN: 1064590X NLM ISO Abbreviation: Food Drug Law J

Original Publication: Washington, DC : Food and Drug Law Institute, c1992-

Animals, Genetically Modified* ; Legislation, Food*; Cloning, Organism/*legislation & jurisprudence ; Consumer Product Safety/*legislation & jurisprudence ; Food Industry/*legislation & jurisprudence ; Food Labeling/*legislation & jurisprudence ; Food Supply/*legislation & jurisprudence; Animals ; Cloning, Organism/adverse effects ; Cloning, Organism/ethics ; Cloning, Organism/methods ; Consumer Behavior ; Epigenesis, Genetic ; Food/adverse effects ; Food/classification ; Food Chain ; Food Industry/ethics ; Food Supply/classification ; Food Supply/ethics ; Government Regulation/history ; History, 19th Century ; History, 20th Century ; Humans ; Risk Assessment ; United States ; United States Food and Drug Administration/history ; United States Food and Drug Administration/legislation & jurisprudence

Animal cloning is "complex process that lets one exactly copy the genetic, or inherited, traits of an animal." In 1997, Dolly the sheep was the first animal cloned and since then "scientists have used animal cloning to breed dairy cows, beef cattle, poultry, hogs and other species of livestock." Cloned animals are highly attractive to livestock breeders because "cloning essentially produces an identical copy of an animal with superior traits." The main purpose of cloning livestock is "more focused on efficiency and economic benefits of the producer rather than the overall effect of cloning on an animal's physical and mental welfare." The focus of this article is threefold. First, the science behind animal cloning is explained and some potential uses and risks of this technology are explored. Second, FDA's historical evolution, current regulatory authority, and limitations of that authority, is described. Lastly, a new regulatory vision recognizes the realities of 21st century global markets and the dynamic evolution of scientific discovery and technology.

Date Created: 20091217 Date Completed: 20091222 Latest Revision: 20141120

20240829

19999640